Are All SGLT2 Inhibitors Created Equal?

被引：4

作者：

Gregg, L. Parker ^{[1
,2
,3
]}

Navaneethan, Sankar D. ^{[1
,2
,3
,4
]}

机构：

[1] Baylor Coll Med, Dept Med, Selzman Inst Kidney Hlth, Sect Nephrol, Houston, TX 77030 USA

[2] Michael E DeBakey VA Med Ctr, Sect Nephrol, Houston, TX USA

[3] Vet Affairs Hlth Serv Res & Dev, Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA

[4] Baylor Coll Med, Inst Clin & Translat Res, Houston, TX 77030 USA

来源：

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 16卷 / 09期

关键词：

eGFR; kidney disease; SGLT2; inhibitors; sodium-glucose cotransporter-2;

D O I：

10.2215/CJN.09720721

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1309 / 1311

页数：3

共 11 条

[1] Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes [J].

Cannon, Christopher P. ;

Pratley, Richard ;

Dagogo-Jack, Samuel ;

Mancuso, James ;

Huyck, Susan ;

Masiukiewicz, Urszula ;

Charbonnel, Bernard ;

Frederich, Robert ;

Gallo, Silvina ;

Cosentino, Francesco ;

Shih, Weichung J. ;

Gantz, Ira ;

Terra, Steven G. ;

Cherney, David Z. I. ;

McGuire, Darren K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1425-1435

[2] Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV Trial [J].

Cherney, David Z. I. ;

Cosentino, Francesco ;

Dagogo-Jack, Samuel ;

McGuire, Darren K. ;

Pratley, Richard ;

Frederich, Robert ;

Maldonado, Mario ;

Liu, Chih-Chin ;

Liu, Jie ;

Pong, Annpey ;

Cannon, Christopher P. .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (09) :1345-1354

[3] Effects of ertugliflozin on kidney composite outcomes, renal function and albuminuria in patients with type 2 diabetes mellitus: an analysis from the randomised VERTIS CV trial [J].

Cherney, David Z. I. ;

Charbonnel, Bernard ;

Cosentino, Francesco ;

Dagogo-Jack, Samuel ;

McGuire, Darren K. ;

Pratley, Richard ;

Shih, Weichung J. ;

Frederich, Robert ;

Maldonado, Mario ;

Pong, Annpey ;

Cannon, Christopher P. .

DIABETOLOGIA, 2021, 64 (06) :1256-1267

[4] Dapagliflozin in Patients with Chronic Kidney Disease [J].

Heerspink, Hiddo J. L. ;

Stefansson, Bergur V. ;

Correa-Rotter, Ricardo ;

Chertow, Glenn M. ;

Greene, Tom ;

Hou, Fan-Fan ;

Mann, Johannes F. E. ;

McMurray, John J. V. ;

Lindberg, Magnus ;

Rossing, Peter ;

Sjostrom, C. David ;

Toto, Roberto D. ;

Langkilde, Anna-Maria ;

Wheeler, David C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1436-1446

[5] GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials [J].

Inker, Lesley A. ;

Heerspink, Hiddo J. L. ;

Tighiouart, Hocine ;

Levey, Andrew S. ;

Coresh, Josef ;

Gansevoort, Ron T. ;

Simon, Andrew L. ;

Ying, Jian ;

Beck, Gerald J. ;

Wanner, Christoph ;

Floege, Juergen ;

Li, Philip Kam-Tao ;

Perkovic, Vlado ;

Vonesh, Edward F. ;

Greene, Tom .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (09) :1735-1745

[6] Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction Results of DAPA-HF [J].

Jhund, Pardeep S. ;

Solomon, Scott D. ;

Docherty, Kieran F. ;

Heerspink, Hiddo J. L. ;

Anand, Inder S. ;

Bohm, Michael ;

Chopra, Vijay ;

de Boer, Rudolf A. ;

Desai, Akshay S. ;

Ge, Junbo ;

Kitakaze, Masafumi ;

Merkley, Bela ;

O'Meara, Eileen ;

Shou, Morten ;

Tereshchenko, Sergey ;

Verma, Subodh ;

Vinh, Pham Nguyen ;

Inzucchi, Silvio E. ;

Kober, Lars ;

Kosiborod, Mikhail N. ;

Martinez, Felipe A. ;

Ponikowski, Piotr ;

Sabatine, Marc S. ;

Bengtsson, Olof ;

Langkilde, Anna Maria ;

Sjostrand, Mikaela ;

McMurray, John J., V .

CIRCULATION, 2021, 143 (04) :298-309

[7] Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure [J].

Packer, Milton ;

Anker, Stefan D. ;

Butler, Javed ;

Filippatos, Gerasimos ;

Pocock, Stuart J. ;

Carson, Peter ;

Januzzi, James ;

Verma, Subodh ;

Tsutsui, Hiroyuki ;

Brueckmann, Martina ;

Jamal, Waheed ;

Kimura, Karen ;

Schnee, Janet ;

Zeller, Cordula ;

Cotton, Daniel ;

Bocchi, Edimar ;

Boehm, Michael ;

Choi, Dong-Ju ;

Chopra, Vijay ;

Chuquiure, Eduardo ;

Giannetti, Nadia ;

Janssens, Stefan ;

Zhang, Jian ;

Juanatey, Jose R. Gonzalez ;

Kaul, Sanjay ;

Brunner-La Rocca, Hans-Peter ;

Merkely, Bela ;

Nicholls, Stephen J. ;

Perrone, Sergio ;

Pina, Ileana ;

Ponikowski, Piotr ;

Sattar, Naveed ;

Senni, Michele ;

Seronde, Marie-France ;

Spinar, Jindrich ;

Squire, Iain ;

Taddei, Stefano ;

Wanner, Christoph ;

Zannad, Faiez .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1413-1424

[8] Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy [J].

Perkovic, V. ;

Jardine, M. J. ;

Neal, B. ;

Bompoint, S. ;

Heerspink, H. J. L. ;

Charytan, D. M. ;

Edwards, R. ;

Agarwal, R. ;

Bakris, G. ;

Bull, S. ;

Cannon, C. P. ;

Capuano, G. ;

Chu, P. -L. ;

De Zeeuw, D. ;

Greene, T. ;

Levin, A. ;

Pollock, C. ;

Wheeler, D. C. ;

Yavin, Y. ;

Zhang, H. ;

Zinman, B. ;

Meininger, G. ;

Brenner, B. M. ;

Mahaffey, K. W. ;

McGuire, Darren K. ;

Holman, Rury ;

Home, Philip ;

Scharfstein, Dan ;

Parfrey, Patrick ;

Shahinfar, Shahnaz ;

August, Phyllis ;

Chang, Tara ;

Sinha, Arjun D. ;

Januzzi, James ;

Kolansky, Daniel ;

Amerena, John ;

Hillis, Graham ;

Gorelick, Philip ;

Kissela, Brett ;

Kasner, Scott ;

Lindley, Richard ;

Fulcher, Greg ;

Ounadjela, Souhila ;

Hufert, Karina ;

von Ingersleben, Gabriele ;

Gaglia, Jason ;

Harris, Ronald ;

Hudson, Margo ;

Turchin, Alexander ;

Cheifetz, Adam .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24) :2295-2306

[9] Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials [J].

Perkovic, Vlado ;

de Zeeuw, Dick ;

Mahaffey, Kenneth W. ;

Fulcher, Greg ;

Erondu, Ngozi ;

Shaw, Wayne ;

Barrett, Terrance D. ;

Weidner-Wells, Michele ;

Deng, Hsiaowei ;

Matthews, David R. ;

Neal, Bruce .

LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (09) :691-704

[10] Empagliflozin and Kidney Function Decline in Patients with Type 2 Diabetes: A Slope Analysis from the EMPA-REG OUTCOME Trial [J].

Wanner, Christoph ;

Heerspink, Hiddo J. L. ;

Zinman, Bernard ;

Inzucchi, Silvio E. ;

Koitka-Weber, Audrey ;

Mattheus, Michaela ;

Hantel, Stefan ;

Woerle, Hans-Juergen ;

Broedl, Uli C. ;

von Eynatten, Maximilian ;

Groop, Per-Henrik ;

Aizenberg, D. ;

Ulla, M. ;

Waitman, J. ;

De Loredo, L. ;

Farias, J. ;

Fideleff, H. ;

Lagrutta, M. ;

Maldonado, N. ;

Colombo, H. ;

Ferre Pacora, F. ;

Wasserman, A. ;

Maffei, L. ;

Lehman, R. ;

Selvanayagam, J. ;

d'Emden, M. ;

Fasching, P. ;

Paulweber, B. ;

Toplak, H. ;

Luger, A. ;

Drexel, H. ;

Prager, R. ;

Schnack, C. ;

Schernthaner, G. ;

Fliesser-Goerzer, E. ;

Kaser, S. ;

Scheen, A. ;

Van Gaal, L. ;

Hollanders, G. ;

Kockaerts, Y. ;

Capiau, L. ;

Chachati, A. ;

Persu, A. ;

Hermans, M. ;

Vantroyen, D. ;

Vercammen, C. ;

Van de Borne, P. ;

Mathieu, C. ;

Benhalima, K. ;

Lienart, F. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (11) :2755-2769

← 1 2 →